Author

Alica Katrin Beutel

PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER
PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER

Alica Katrin Beutel

PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS AS A PERSONALIZED PRECLINICAL TOOL FOR DRUG RESPONSE PREDICTION
PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS AS A PERSONALIZED PRECLINICAL TOOL FOR DRUG RESPONSE PREDICTION

Alica Katrin Beutel  et al.

PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER
PRECLINICAL VALIDATION OF NOVEL GENOTYPE-SPECIFIC THERAPEUTIC CONCEPTS FOR ATM-DEFICIENT PANCREATIC CANCER

Alica Katrin Beutel  et al.

A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE
A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE

Alica Katrin Beutel  et al.

A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE
A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE

MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY
MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY

Alica Katrin Beutel  et al.

SERUM IGG4 LEVELS OUTPERFORM IGG4/IGG RNA RATIO IN DIFFERENTIAL DIAGNOSIS OF IGG4-RELATED DISEASE
SERUM IGG4 LEVELS OUTPERFORM IGG4/IGG RNA RATIO IN DIFFERENTIAL DIAGNOSIS OF IGG4-RELATED DISEASE

Alica Katrin Beutel  et al.

ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS
ATM AND P53 AUTONOMOUS ROLES DURING PANCREATIC CANCER TUMORIGENESIS

Alica Katrin Beutel  et al.

Item 1 - 8 / 8
1